Richard Hoyt
Président chez ZYUS LIFE SCIENCES CORPORATION
Fortune : 119 720 $ au 31/05/2024
Profil
Richard Hoyt is currently the Chairman at ZYUS Life Sciences, Inc. and ZYUS Life Sciences Corp.
He is also the Managing Partner at Ozark Transaction Advisors LLC and the Vice President-Business Development at Xeris Biopharma Holdings, Inc. In the past, he has worked as the Director at Biotechnology Research & Development Corp., Independent Director at CanniMed Therapeutics, Inc., Vice President-Business Development at Xeris Pharmaceuticals, Inc., and Vice President-Business Development & Licensing at Mallinckrodt Plc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2023 | 151 108 ( 0,21% ) | 119 720 $ | 31/05/2024 |
Postes actifs de Richard Hoyt
| Sociétés | Poste | Début |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Président | 01/09/2020 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | - |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Président | - |
| Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Anciens postes connus de Richard Hoyt
| Sociétés | Poste | Fin |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 01/09/2018 |
| CANNIMED THERAPEUTICS INC | Directeur/Membre du Conseil | 15/03/2018 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| ZYUS LIFE SCIENCES CORPORATION | Health Technology |
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
| Ozark Transaction Advisors LLC |
